Do more with MiSight® 1 day*†1 The #1 most prescribed contact lens for kids.‡2

Back-to-school resources for your practice

Get everything you need to educate about myopia, engage with parents and drive more families into your practice.

Download Full Toolkit

Grow your practice with MiSight® this school year

Hear from real eye care professionals who have successfully integrated MiSight® into their practices and seen firsthand its impact on patient outcomes and business growth. By offering a myopia management solution that helps protect children’s vision for the future, these doctors have strengthened family trust, increased patient referrals and built a foundation for long-term practice success.*†§1,3

Ready to get started?

Our CooperVision representatives are here with tools and resources that make it easy.

Get in Touch

Why practices choose MiSight® 1 day

Correcting their vision isn’t enough. Talk to parents about MiSight® 1 day, the first and only FDA-approved* soft contact lens proven to help slow myopia progression in children.†1

Contact lens icon

Proven myopia control

Shown to slow the progression of myopia by 59% on average.†1

Clipboard checklist icon

Long-term clinical evidence

Backed by the longest continuous international soft contact lens study among children.

9/10 icon

Clear vision,1,4,5 with comfortable lenses4

Nearly 9 out of 10 children preferred MiSight® 1 day over their glasses.4

Approval ribbon icon

FDA-approved*

The first FDA-approved* soft contact lens proven to slow myopia progression in children.†1

More MiSight® 1 day resources

Benefits of Switching PDF thumbnail

Why single-vision contact lenses aren't enough

Compare MiSight® 1 day with single-vision contacts to support more informed treatment decisions.

Download

Expert endorsements PDF thumbnail

Expert endorsements

Show parents why myopia management is today’s standard of care.6

Download

Finding the right fit PDF thumbnail

Finding the right fit

Help parents choose a myopia control option that fits their child’s daily life.

Download

ECP Viewpoints logo

Ongoing education

Explore clinical articles and expert podcasts to strengthen your myopia conversations.

Read More

We’re here to support you.

Fill out this form to connect with a myopia specialist and access training tools and resources to help your team expand myopia management adoption and grow your practice with MiSight®.

By submitting this form, you grant CooperVision, Inc. permission to add your contact information to our database to send you information and communications related to our products and services. The use of personal contact information will be treated in accordance with CooperVision's Privacy Policy.

* Indications for use: MiSight® 1 day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75D to -4.00D (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

† Compared to a single-vision 1-day lens over a 3-year period.

‡ MiSight® 1 day represents 15% of soft contact lense fits on kids ages 8-12 vs. 12% for the next most fit soft contact lens.

§ MiSight® 1 day, designed for myopia control, shows sustained slowing of eye growth over time on average. While eyes are still growing; children fit ages 8-12 and followed for 6-years. n=40.

References:

  1. Chamberlain P et al A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019;96:556-567.
  2. CVI data on file, 2026. US industry Reports and internal estimates, Q4 2025.
  3. Chamberlain P et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
  4. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation.
  5. Chamberlain P et al. Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. BCLA paper presentation 2019.
  6. Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopia-management-by-optometrists.

 

20096 09/26